Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
09/15/2009
Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients with Type 2 Diabetes
09/09/2009
Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
09/02/2009
Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference
08/04/2009
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients with Rheumatoid Arthritis
07/28/2009
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
07/22/2009
Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
07/21/2009
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
07/07/2009
Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients with Carcinoid Syndrome
06/02/2009
Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
05/27/2009
Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 4 of 37
